Cooke & Bieler’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,514,281
Closed -$102M 98
2024
Q2
$102M Buy
3,514,281
+388,710
+12% +$11.5M 0.99% 45
2024
Q1
$111M Buy
3,125,571
+290,967
+10% +$11.6M 1.02% 46
2023
Q4
$123M Buy
2,834,604
+120,410
+4% +$4.74M 1.09% 40
2023
Q3
$104M Sell
2,714,194
-25,460
-0.9% -$1.07M 1.01% 44
2023
Q2
$113M Buy
2,739,654
+79,083
+3% +$3.81M 1.05% 38
2023
Q1
$153M Sell
2,660,571
-71,495
-3% -$4.03M 1.49% 20
2022
Q4
$153M Sell
2,732,066
-793
-0% -$40.4K 1.5% 23
2022
Q3
$116M Buy
2,732,859
+239,485
+10% +$12.3M 1.24% 34
2022
Q2
$135M Sell
2,493,374
-36,045
-1% -$2.16M 1.3% 31
2022
Q1
$163M Buy
2,529,419
+152,293
+6% +$10M 1.43% 26
2021
Q4
$159M Sell
2,377,126
-4,480
-0.2% -$303K 1.37% 25
2021
Q3
$163M Sell
2,381,606
-368,755
-13% -$26.1M 1.48% 19
2021
Q2
$188M Buy
2,750,361
+50,912
+2% +$3.6M 1.73% 16
2021
Q1
$187M Sell
2,699,449
-11,284
-0.4% -$764K 1.81% 14
2020
Q4
$176M Buy
2,710,733
+244,503
+10% +$13.2M 1.92% 11
2020
Q3
$116M Buy
2,466,230
+165,780
+7% +$7.89M 1.55% 24
2020
Q2
$108M Buy
2,300,450
+70,985
+3% +$3.49M 1.48% 28
2020
Q1
$99.6M Buy
2,229,465
+474,005
+27% +$24.9M 1.6% 19
2019
Q4
$102M Buy
+1,755,460
New +$105M 1.1% 43

Other funds holding IART

Cooke & Bieler's IART Position: Q3 2024 in Review

Cooke & Bieler sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 3,514,281 shares — an estimated $102M sold.

Cooke & Bieler first reported a position in IART in Q4 2019 and held it in 19 quarters. The position peaked at $188M in Q2 2021. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Cooke & Bieler reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Cooke & Bieler sold 3,514,281 Integra LifeSciences shares in Q3 2024, an estimated $102M.
  • Cooke & Bieler first reported a position in Integra LifeSciences in Q4 2019 and held it in 19 quarters.
  • Cooke & Bieler's Integra LifeSciences position peaked at $188M in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Cooke & Bieler's 13F filing for Q3 2024, filed 8 Nov 2024.